Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Villa

Showing results (561-570 of 566) with videos related to

Pageof 57
Sort By:
You have reached the last page of results.This site can display upto 566 results.
The Journal of Infectious Diseases|February 25, 2009
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 yearsCosette M Wheeler, Susanne K Kjaer, Kristján Sigurdsson, et al.
Vaccine|October 22, 2008
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccineElmar A Joura, Susanne K Kjaer, Cosette M Wheeler, et al.
The Journal of Infectious Diseases|February 25, 2009
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 yearsDarron R Brown, Susanne K Kjaer, Kristján Sigurdsson, et al.
Journal of the National Cancer Institute|February 9, 2010
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young womenNubia Muñoz, Susanne K Kjaer, Kristján Sigurdsson, et al.
Nature Communications|November 7, 2022
Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancerAriane F Busso-Lopes, Leandro X Neves, Guilherme A Câmara, et al.
PLOS Global Public Health|April 9, 2025
Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in researchN Venkatesan, L Faust, R Lobo, et al.
Pageof 57

Showing results (561-570 of 566) with videos related to

Sort By:
Pageof 57
You have reached the last page of results.This site can display upto 566 results.
The Journal of Infectious Diseases|February 25, 2009
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 yearsCosette M Wheeler, Susanne K Kjaer, Kristján Sigurdsson, et al.
Vaccine|October 22, 2008
HPV antibody levels and clinical efficacy following administration of a prophylactic quadrivalent HPV vaccineElmar A Joura, Susanne K Kjaer, Cosette M Wheeler, et al.
The Journal of Infectious Diseases|February 25, 2009
The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 yearsDarron R Brown, Susanne K Kjaer, Kristján Sigurdsson, et al.
Journal of the National Cancer Institute|February 9, 2010
Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young womenNubia Muñoz, Susanne K Kjaer, Kristján Sigurdsson, et al.
Nature Communications|November 7, 2022
Connecting multiple microenvironment proteomes uncovers the biology in head and neck cancerAriane F Busso-Lopes, Leandro X Neves, Guilherme A Câmara, et al.
PLOS Global Public Health|April 9, 2025
Fighting tuberculosis hand in hand: A call to engage communities affected by TB as essential partners in researchN Venkatesan, L Faust, R Lobo, et al.
Pageof 57